These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8769217

  • 41. Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes.
    Citterio F, Serino F, Pozzetto U, Fioravanti P, Caizzi P, Castagneto M.
    Transplant Proc; 1996 Aug; 28(4):2174-6. PubMed ID: 8769192
    [No Abstract] [Full Text] [Related]

  • 42. Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program.
    Mueller EA, Kovarik JM, Pittrow D.
    Transplant Proc; 1998 Aug; 30(5):1691-3. PubMed ID: 9723246
    [No Abstract] [Full Text] [Related]

  • 43. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
    Cooney GF, Lum BL, Meligeni JA, Dunn SP.
    Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
    Gentil Govantes MA, Gómez Ullate P, Errasti P, Fernández Fresnedo G, Capdevila L, Sanz Guajardo A, Cubero JJ.
    Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
    [No Abstract] [Full Text] [Related]

  • 48. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR, Weiskittel P, Shah M, Peddi VR, Canafax D, Schroeder TJ.
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract] [Full Text] [Related]

  • 49. The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
    Schultz KR, Nevill TJ, Toze CL, Corr T, Currie C, Strong DK, Keown PA.
    Transplant Proc; 1998 Aug; 30(5):1668-70. PubMed ID: 9723236
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Changing stable heart transplant recipients from Sandimmune to Neoral.
    Dalrymple-Hay M, Meara M, Reynolds L, Backhouse L, Wright D, Holt D, Johnston A, Madden B, Murday A.
    Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
    Wilczek HE, Berglin E, Blohmé I, Bäckman L, Fehrman I, Källen R, Nyberg G, Säwe J, Wahlberg J.
    Transplant Proc; 1997 Aug; 29(1-2):280-3. PubMed ID: 9122995
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.